Thyroid Adenocarcinoma: Mutation Analysis (MutSig vS2N)
(other cohort)
Maintained by Dan DiCara (Broad Institute)
Overview
Introduction

This report serves to describe the mutational landscape and properties of a given individual set, as well as rank genes and genesets according to mutational significance. MutSig vS2N was used to generate the results found in this report.

  • Working with individual set: THCA-other

Input

The input for this pipeline is a set of individuals with the following files associated for each:

  1. An annotated .maf file describing the mutations called for the respective individual, and their properties.

  2. A .wig file that contains information about the coverage of the sample.

Summary
Results
Significantly Mutated Genes

Column Descriptions:

  • N = number of sequenced bases in this gene across the individual set

  • nnon = number of (nonsilent) mutations in this gene across the individual set

  • nnull = number of (nonsilent) null mutations in this gene across the individual set

  • nflank = number of noncoding mutations from this gene's flanking region, across the individual set

  • nsil = number of silent mutations in this gene across the individual set

  • p = p-value (overall)

  • q = q-value, False Discovery Rate (Benjamini-Hochberg procedure)

Table 1.  Get Full Table A Ranked List of Significantly Mutated Genes. Number of significant genes found: 1. Number of genes displayed: 35. Click on a gene name to display its stick figure depicting the distribution of mutations and mutation types across the chosen gene (this feature may not be available for all significant genes).

gene N nflank nsil nnon nnull p q
BRAF 4959 0 0 4 0 3.2e-149 6e-145
DNAH2 30667 0 0 2 0 1 1
DNAH9 30381 0 0 2 0 1 1
EHBP1 8370 0 0 2 0 1 1
EIF1AX 1064 0 0 2 1 1 1
FREM1 13571 0 0 2 0 1 1
HRAS 1319 0 0 2 0 1 1
IRS1 6402 0 0 2 0 1 1
NRAS 1396 0 0 2 0 1 1
TRIM46 4198 0 0 2 0 1 1
ABHD4 2119 0 0 1 0 1 1
ABP1 4540 0 0 1 1 1 1
ACAD10 6744 0 0 1 0 1 1
ADH4 2603 0 0 1 0 1 1
ADRB1 1591 0 0 1 0 1 1
AKAP11 13299 0 0 1 1 1 1
AKAP8L 3371 0 0 1 1 1 1
ALG3 2982 0 0 1 0 1 1
ALPK1 8398 0 0 1 0 1 1
AMAC1 1824 0 0 1 0 1 1
AMY2A 1806 0 0 1 0 1 1
ANK1 12371 0 0 1 0 1 1
ANTXR2 2198 0 0 1 0 1 1
AP3B1 7883 0 0 1 0 1 1
APOB 33372 0 0 1 0 1 1
ARHGAP29 9119 0 0 1 1 1 1
ARID2 11505 0 0 1 1 1 1
ATM 22860 0 0 1 0 1 1
ATRNL1 9384 0 0 1 1 1 1
BAT2 9441 0 0 1 0 1 1
BCAR3 5187 0 0 1 0 1 1
BCAT1 2566 0 0 1 1 1 1
BDP1 18135 0 0 1 0 1 1
BLMH 3391 0 0 1 0 1 1
BMS1 8743 0 0 1 0 1 1
Methods & Data
Methods

In brief, we tabulate the number of mutations and the number of covered bases for each gene. The counts are broken down by mutation context category: four context categories that are discovered by MutSig, and one for indel and 'null' mutations, which include indels, nonsense mutations, splice-site mutations, and non-stop (read-through) mutations. For each gene, we calculate the probability of seeing the observed constellation of mutations, i.e. the product P1 x P2 x ... x Pm, or a more extreme one, given the background mutation rates calculated across the dataset. [1]

Download Results

This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.

References
[1] TCGA, Integrated genomic analyses of ovarian carcinoma, Nature 474:609 - 615 (2011)